-
Sprint Fidelis Lead Wire Failure Rate Could Rise To 30 Percent By Four Years
About 260,000 Medtronic Sprint Fidelis Leads Were Implanted In US, With Approximately 143,000 Still Active (Posted by Tom Lamb at DrugInjuryWatch.com) The December 28, 2009 edition of "US Morning Meeting Highlights" from UBS Investment…
-
A New Year’s Resolution For The FDA, As Recommended By The GAO
FDA Needs To Restructure Its Staff In Order To Better Monitor Emerging Drug Safety Issues (Posted by Tom Lamb at DrugInjuryWatch.com) In mid-December 2009 the Government Accounting Agency (GAO) — often referred to as…
-
FDA Finds It Unlikely That Vytorin Or Zetia Increases Risk Of Cancer, But Such A Link Is Possible
December 2009 Update From FDA For Its August 2008 Early Communication About Safety Review of Ezetimibe / Simvastatin (Vytorin) And Ezetimibe (Zetia) (Posted by Tom Lamb at DrugInjuryWatch.com) On December 22, 2009 the FDA…
-
Digitek Federal Court MDL Judge Sets Joint Hearing To Address Scientific And Technical Issues For October 2010
Judge Goodwin Will Be Joined By State Court Judges Overseeing Digitek Consolidations In New Jersey, Pennsylvania, Texas, And West Virginia At This Daubert Hearing (Posted by Tom Lamb at DrugInjuryWatch.com) On December 18, 2009…
-
December 2009: Voltaren Gel And Other Products Containing Diclofenc Sodium Linked To Liver Problems
"Dear Doctor" Letter From Endo And Novartis Offers Information About Prevention And Diagnosis Of Drug-Induced Liver Injury (DILI) (Posted by Tom Lamb at DrugInjuryWatch.com) On December 4, 2009 the FDA issued this MedWatch alert, "Voltaren…